Kaempferol 3-apioside-7-rhamnosyl-(1->6)-(2\'\'-(E)-caffeoylglactoside)



Compound IDCDAMM02729
Common nameKaempferol 3-apioside-7-rhamnosyl-(1->6)-(2\'\'-(E)-caffeoylglactoside)
IUPAC name[2-[3-[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-4,5-dihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-3-yl] 3-(3,4-dihydroxyphenyl)prop-2-enoate
Molecular formulaC41H44O22

Experimental data

Retention time5.34
Adduct[M+H]+
Actual mz889.244
Theoretical mz889.239
Error4.75
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.3274

Identifiers and class information

Inchi keyAUTADROYLXMWLA-HLZORXINNA-N
SmilesO=C(OC1C(O)C(O)C(OC1OC2=CC(O)=C3C(=O)C(OC4OCC(O)(CO)C4O)=C(OC3=C2)C=5C=CC(O)=CC5)COC6OC(C)C(O)C(O)C6O)C=CC7=CC=C(O)C(O)=C7
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)16
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)24
Number of reactive functional groups (#rtvFG)4
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)888.785
Computed dipole moment(dipole)5.318
Total solvent accessible surface area (SASA)1245.27
Hydrophobic component of SASA (FOSA)361.054
Hydrophilic component of SASA (FISA)540.206
Pie component of the SASA (PISA)344.011
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2389.51
Number of hydrogen bond donors (donorHB)11
Number of hydrogen bond acceptors (accptHB)27.45
Free energy of solvation of dipole (dip^2/V)0.0118353
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0731097
Globularity descriptor (glob)0.694129
Predicted polarizability in cubic angstroms (QPpolrz)77.349
Predicted hexadecane/gas partition coefficient (QPlogPC16)30.289
Predicted octanol/gas partition coefficient (QPlogPoct)58.453
Predicted water/gas partition coefficient (QPlogPw)46.585
Predicted octanol/water partition coefficient (QPlogPo/w)-1.876
Predicted aqueous solubility (QPlogS)-4.426
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.893
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-8.122
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.075
Predicted brain/blood partition coefficient (QPlogBB)-8.358
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.017
Predicted skin permeability, log Kp (QPlogKp)-7.959
PM3 calculated ionization potential (IP(ev))9.028
PM3 calculated electron affinity (EA(eV))0.892
Number of likely metabolic reactions (#metab)12
Prediction of binding to human serum albumin (QPlogKhsa)-1.669
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)361.314
Number of nitrogen and oxygen atoms (#NandO)22
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43166CA7Carbonic anhydrase VIIT37541SEA
P22748CA4Carbonic anhydrase IVT53378SEA
P15121AKR1B1Aldose reductaseT26623SEA
P60568IL2Interleukin-2T61698SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
P47989XDHXanthine dehydrogenaseT40954SEA
O43826SLC37A4Glucose-6-phosphate translocaseT47306SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T26623DI0298Neuropathy[ICD-11: 8C0Z]P15121AKR1B1
T26623DI0366Rheumatoid arthritis[ICD-11: FA20]P15121AKR1B1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T40954DI0206Inborn purine/pyrimidine/nucleotide metabolism error[ICD-11: 5C55]P47989XDH
T40954DI0266Mineral deficiency[ICD-11: 5B5K]P47989XDH
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025